Symbol
| CYP2E1
| contributors: mct/pgu - updated : 20-05-2011
|
HGNC name
| cytochrome P450, family 2, subfamily E, polypeptide 1
|
HGNC id
| 2631
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
significantly decreased mRNA expression in patients with fibrotic and inflammatory lung diseases compared to healthy controls | |
Susceptibility
|
to lung adenocarcinoma and to alcoholism to acute lymphoblastic leukemia(ALL) to oral clefts to head and neck cancer to alcoholic cirrhosis |
Variant & Polymorphism
other
| variant 5 increases the risk of ALL |
|
homozygote genotypes of PstI/RsaI or DraI polymorphism might be associated with an increased risk of head and neck cancer |
|
combination of variant genotype of CYP2E1 5B with GABRG2, significantly increased the risk of alcoholic cirrhosis |
|
|
Candidate gene
Marker
Therapy target
| | | |